Committee on Government Reform, Minority Office; Rep. Henry A. Waxman, Ranking Member

Democratic Medicare Drug Reforms Could Save Seniors Billions of Dollars

Democratic members of Congress have proposed reforms of the Medicare drug benefit that could save the average senior almost $500 per year and eliminate the donut hole, without any increased costs to the taxpayer.

Administration Oversight, Open Government

Restoring Honesty and Accountability in Washington

Over the last five years, public confidence in the federal government has plummeted. Reports of enormous waste, fraud, and abuse have squandered both taxpayer dollars and public support. Rep. Henry A. Waxman and Democratic Members of the Committee on Government Reform have developed six proposals to restore honesty and accountability in government.

Wednesday, November 01, 2006

Food Safety

Weaknesses in FDA's Food Safety System

Rep. Waxman releases a fact sheet explaining that the growing incidence of contamination in fresh produce is a symptom of weaknesses in the federal food safety system.

Wednesday, October 25, 2006

Administration Oversight

Bush Cabinet Secretaries Have Frequently Traveled on Private Jets at Taxpayer Expense

Rep. Waxman reveals that Bush agency heads have taken 125 trips to over 300 locations aboard private jets, helicopters, and other aircraft at taxpayer expense and urges OMB Director Rob Portman to impose a moratorium on this luxury travel.

Wednesday, October 25, 2006

Terrorism

Senior Democrats Reject Superficial Bush Counterterrorism Plan Before Elections

Rep. Waxman joins senior Democratic members of Congress in rejecting President Bush's decision to roll out a superficial counterterrorism plan directly before midterm elections.

Monday, October 23, 2006

Prescription Drugs

Based on Claritin-D Advertisement, Rep. Waxman Renews Request That FDA Investigate Phenylephrine Oral Nasal Decongestants

Citing a new Claritin-D advertisement, Rep. Waxman renews his request that the FDA investigate whether phenylephrine oral nasal decongestants are effective. In the ad, Schering-Plough announced that it will not reformulate Claritin-D, a pseudoephedrine-based oral nasal decongestant, to switch to phenylephrine.